Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease

Shana D Stites, Richard Milne, Jason Karlawish, Shana D Stites, Richard Milne, Jason Karlawish

Abstract

Neuroimaging is advancing a new definition of Alzheimer's disease (AD). Using imaging biomarkers, clinicians may begin to diagnose the disease by identifying pathology and neurodegeneration in either cognitively impaired or unimpaired adults. This "biomarker-based" diagnosis may allow clinicians novel opportunities to use interventions that either delay the onset or slow the progression of cognitive decline, but it will also bring novel challenges. How will changing the definition of AD from a clinical to a biomarker construct change the experience of living with the disease? Knowledge of AD biomarker status can affect how individuals feel about themselves (internalized stigma) and how others judge them (public stigma). Following a review of AD stigma, we appraise how advances in diagnosis may enable or interrupt its transfer from clinical to preclinical stages and then explore conceptual and pragmatic challenges to addressing stigma in routine care.

Keywords: Alzheimer's disease; Early diagnosis; Stigma.

Figures

Fig. 1
Fig. 1
Aspects of personal identity and disease beliefs intersect to alter stigma of Alzheimer's disease dementia. Abbreviation: SMI, serious mental illness.

References

    1. Goffman E. Prentice-Hall; Englewood Cliffs, N.J: 1963. Stigma; Notes on the Management of Spoiled Identity.
    1. Scambler G. Health-related stigma. Sociol Health Illn. 2009;31:441–455.
    1. Pescosolido B.A., Martin J.K. The stigma complex. Annu Rev Sociol. 2015;41:87–116.
    1. Corrigan P.W. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work. 2007;52:31–39.
    1. Mukadam N., Livingston G. Reducing the stigma associated with dementia: approaches and goals. Aging Health. 2012;8:377–386.
    1. Behuniak S.M. The living dead? The construction of people with Alzheimer's disease as zombies. Ageing Soc. 2011;31:70–92.
    1. Stites S.D., Johnson R., Harkins K., Sankar P., Xie D., Karlawish J. Identifiable characteristics and potentially malleable beliefs predict stigmatizing attributions toward persons with Alzheimer's disease dementia: results of a survey of the U.S. General Public. Health Commun. 2018;33:264–273.
    1. Graham N., Lindesay J., Katona C., Bertolote J.M., Camus V., Copeland J.R. Reducing stigma and discrimination against older people with mental disorders: a technical consensus statement: reducing stigma and discrimination against older people with mental disorders. Int J Geriatr Psychiatry. 2003;18:670–678.
    1. Sperling R.A., Rentz D.M., Johnson K.A., Karlawish J., Donohue M., Salmon D.P. The A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014;228:228fs13.
    1. Link B.G., Phelan J.C. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363–385.
    1. Link B.G., Phelan J.C. Labeling and Stigma. In: Aneshensel C.S., Phelan J.C., Bierman A., editors. Handbook of the Sociology of Mental Health. Springer Netherlands; Dordrecht: 2013. pp. 525–541.
    1. Kirkman A.M. Dementia in the news: the media coverage of Alzheimer's disease. Australas J Ageing. 2006;25:74–79.
    1. Pin Le Corre S., Scodellaro C., Arwidson P. The image of patients and caregivers in the social perception of Alzheimer's disease–results from a literature review and a qualitative study considered with this target. Alzheimers Dement. 2009;5:P233.
    1. Werner P., Goldstein D., Buchbinder E. Subjective experience of family stigma as reported by children of Alzheimer's disease patients. Qual Health Res. 2010;20:159–169.
    1. Van Gorp B., Vercruysse T. Frames and counter-frames giving meaning to dementia: A framing analysis of media content. Soc Sci Med. 2012;74:1274–1281.
    1. Johnson R., Harkins K., Cary M., Sankar P., Karlawish J. The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment. Soc Sci Med. 2015;143:117–127.
    1. Werner P., Goldstein D., Heinik J. Development and validity of the family stigma in Alzheimer's disease scale (FS-ADS) Alzheimer Dis Assoc Disord. 2011;25:42–48.
    1. Garand L., Lingler J.H., Conner K.O., Dew M.A. Diagnostic labels, stigma, and participation in research related to dementia and mild cognitive impairment. Res Gerontol Nurs. 2009;2:112–121.
    1. Beard R.L., Neary T.M. Making sense of nonsense: experiences of mild cognitive impairment: Sense-making in mild cognitive impairment experiences. Sociol Health Illn. 2013;35:130–146.
    1. Cohen L. University of California Press; Berkeley, Calif: 2000. No Aging in India: Alzheimer's, The Bad Family, and Other Modern Things.
    1. Batsch N.L., Mittleman M.S. Alzheimer's Disease International; London, UK: 2012. World Alzheimer Report 2012, Overcoming the Stigma of Dementia. Available at: .
    1. Weiner B., Perry R.P., Magnusson J. An attributional analysis of reactions to stigmas. J Pers Soc Psychol. 1988;55:738–748.
    1. Pescosolido B.A., Medina T.R., Martin J.K., Long J.S. The ‘Backbone’ of stigma: identifying the global core of public prejudice associated with mental illness. Am J Public Health. 2013;103:853–860.
    1. Liu D., Hinton L., Tran C., Hinton D., Barker J.C. Reexamining the relationships among dementia, stigma, and aging in immigrant Chinese and Vietnamese family caregivers. J Cross Cult Gerontol. 2008;23:283–299.
    1. Fiske S.T., Cuddy A.J.C., Glick P., Xu J. A model of (often mixed) stereotype content: Competence and warmth respectively follow from perceived status and competition. J Pers Soc Psychol. 2002;82:878–902.
    1. Kane M.N. Awareness of ageism, motivation, and countertransference in the care of elders with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2002;17:101–109.
    1. Caspermeyer J.J., Sylvester E.J., Drazkowski J.F., Watson G.L., Sirven J.I. Evaluation of stigmatizing language and medical errors in neurology coverage by US newspapers. Mayo Clin Proc. 2006;81:300–306.
    1. Handbook of Mental Health and Aging–2nd Edition. 1992. Available at:
    1. Dobbs D., Eckert J.K., Rubinstein B., Keimig L., Clark L., Frankowski A.C. An ethnographic study of stigma and ageism in residential care or assisted living. Gerontologist. 2008;48:517–526.
    1. Milne A. The ‘D’ word: Reflections on the relationship between stigma, discrimination and dementia. J Ment Health. 2010;19:227–233.
    1. Calasanti T.M., Slevin K.F. Rowman Altamira; Walnut Creek, CA: 2001. Gender, Social Inequalities, and Aging.
    1. Bouldin E., Andresen E. Caregiving across the United States: BRFSS data reveal the impact of Alzheimer's disease and dementia. Alzheimers Dement. 2012;8:599.
    1. Freedman V.A., Spillman B.C. Disability and care needs among older Americans: disability and care needs of older Americans. Milbank Q. 2014;92:509–541.
    1. Stites S.D., Rubright J.D., Karlawish J. What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? results of a survey of the U.S. general public [published online ahead of print March 27, 2018] Alzheimers Dement. 2018
    1. Darnell K.R., McGuire C., Danner D.D. African American Participation in Alzheimer's Disease Research That Includes Brain Donation. Am J Alzheimers Dis Other Dement. 2011;26:469–476.
    1. Heatherton T.F. Guilford Press; New York, NY: 2003. The Social Psychology of Stigma.
    1. Shavers-Hornaday V.L., Lynch C.F., Burmeister L.F., Torner J.C. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health. 1997;2:31–45.
    1. Noonan A.S., Velasco-Mondragon H.E., Wagner F.A. Improving the health of African Americans in the USA: an overdue opportunity for social justice. Public Health Rev. 2016;37:12.
    1. Green R.C. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002;287:329–336.
    1. Phillipson L., Magee D.C., Jones S., Skladzien D.E., Cridland E. Exploring dementia and stigma beliefs. Alzheimers Aust. 2012 Available at: . Accessed March 20, 2018.
    1. Crisp A.H. Stigmatisation of people with mental illnesses. Br J Psychiatry. 2000;177:4–7.
    1. Burgener S.C., Berger B. Measuring perceived stigma in persons with progressive neurological disease: Alzheimer's dementia and Parkinson's disease. Dementia. 2008;7:31–53.
    1. Alzheimer's Association National Plan Milestone Workgroup 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimers Dement. 2014;10(5 Suppl):S430–452.
    1. Anderson L.A., Egge R. Expanding efforts to address Alzheimer's disease: the Healthy Brain Initiative. Alzheimers Dement. 2014;10(5 Suppl):S453–456.
    1. Connell C.M., Shaw B.A., Holmes S.B., Foster N.L. Caregivers' Attitudes Toward Their Family Members' Participation in Alzheimer Disease Research: Implications for Recruitment and Retention. Alzheimer Dis Assoc Disord. 2001;15:137–145.
    1. Link BG, Cullen FT, Mirotznik J, Struening E. The consequences of stigma for persons with mental illness: Evidence from the social sciences. 1992.
    1. Shifflett P.A., Blieszner R. Stigma and Alzheimer's disease: behavioral consequences for support groups. J Appl Gerontol. 1988;7:147–160.
    1. Scheff T.J. University of Chicago Press; London, UK: 1994. Microsociology: Discourse, Emotion, and Social Structure.
    1. Ownby R.L., Harwood D.G., Barker W.W., Duara R. Predictors of anxiety in patients with Alzheimer's disease. Depress Anxiety. 2000;11:38–42.
    1. Mega M.S., Cummings J.L., Fiorello T., Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130–135.
    1. Riley R.J., Burgener S., Buckwalter K.C. Anxiety and Stigma in Dementia. Nurs Clin North Am. 2014;49:213–231.
    1. Farias S.T., Mungas D., Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005;20:827–834.
    1. Zanetti O., Vallotti B., Frisoni G.B., Geroldi C., Bianchetti A., Pasqualetti P. Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. J Gerontol B Psychol Sci Soc Sci. 1999;54:P100–P106.
    1. McDaniel K.D., Edland S.D., Heyman A. Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer's Disease. Alzheimer Dis Assoc Disord. 1995;9:101–104.
    1. Schmand B., Jonker C., Hooijer C., Lindeboom J. Subjective memory complaints may announce dementia. Neurology. 1996;46:121–125.
    1. Jolley D.J., Benbow S.M. Stigma and Alzheimer's disease: causes, consequences and a constructive approach. Int J Clin Pract. 2000;54:117–119.
    1. Cox C.B. 1st ed. Springer Publishing Company; New York: 2007. Dementia and Social Work Practice: Research and Interventions.
    1. Aneshensel C.S., Pearlin L.I., Schuler R.H. Stress, role captivity, and the cessation of caregiving. J Health Soc Behav. 1993;34:54–70.
    1. Park S., Park K.S. Family stigma: a concept analysis. Asian Nurs Res. 2014;8:165–171.
    1. Francesca C., Ana L.-N., Jérôme M., Frits T. OECD Publishing; OECD Health Policy Studies: 2011. Help Wanted? Providing and Paying for Long-Term Care: Providing and Paying for Long-Term Care.
    1. Allen M.N., Dublin S., Kimmerly P.J. Demos Med Publishing; New York, NY: 2012. A Look Inside Alzheimer's.
    1. Ballard C., Boyle A., Bowler C., Lindesay J. Anxiety disorders in dementia sufferers. Int J Geriatr Psychiatry. 1996;11:987–990.
    1. Steele C.M., Aronson J. Stereotype threat and the intellectual test performance of African Americans. J Pers Soc Psychol. 1995;69:797–811.
    1. Lineweaver T.T., Bondi M.W., Galasko D., Salmon D.P. Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry. 2014;171:201–208.
    1. Werner P., Mittelman M.S., Goldstein D., Heinik J. Family stigma and caregiver burden in Alzheimer's disease. Gerontologist. 2012;52:89–97.
    1. MacRae H. Managing courtesy stigma: the case of Alzheimer's disease. Sociol Health Illn. 2008;21:54–70.
    1. Carretero S., Garcés J., Ródenas F., Sanjosé V. The informal caregiver's burden of dependent people: Theory and empirical review. Arch Gerontol Geriatr. 2009;49:74–79.
    1. Werner P. Social distance towards a person with Alzheimer's disease. Int J Geriatr Psychiatry. 2005;20:182–188.
    1. Drennan V.M., Cole L., Iliffe S. A taboo within a stigma? a qualitative study of managing incontinence with people with dementia living at home. BMC Geriatr. 2011;11:75.
    1. Kahn P.V., Wishart H.A., Randolph J.S., Santulli R.B. Caregiver stigma and burden in memory disorders: an evaluation of the effects of caregiver type and gender. Curr Gerontol Geriatr Res. 2016;2016:8316045.
    1. Pinquart M., Sörensen S. Differences between caregivers and noncaregivers in psychological health and physical health: A meta-analysis. Psychol Aging. 2003;18:250–267.
    1. Mannion E. Alzheimer's disease: the psychological and physical effects of the caregiver's role. Part 2. Nurs Older People. 2008;20:33–38.
    1. McParland P., Devine P., Innes A., Gayle V. Dementia knowledge and attitudes of the general public in Northern Ireland: an analysis of national survey data. Int Psychogeriatr. 2012;24:1600–1613.
    1. Joyce M.L. The graying of America: implications and opportunities for health marketers. Am Behav Sci. 1994;38:341–350.
    1. Van Gorp B., Vercruysse T., Van den Bulck J. Toward a more nuanced perception of Alzheimer's disease: designing and testing a campaign advertisement. Am J Alzheimers Dis Dementiasr. 2012;6:388–396.
    1. Melzer D. New drug treatment for Alzheimer's disease: lessons for healthcare policy. BMJ. 1998;316:762–764.
    1. Bartels S.J., Colenda C.C. Mental Health Services for Alzheimer's Disease: Current trends in reimbursement and public policy, and the future under managed care. Am J Geriatr Psychiatry. 1998;6:S85–S100.
    1. Khachaturian A.S., Hoffman D.P., Frank L., Petersen R., Carson B.R., Khachaturian Z.S. Zeroing out preventable disability: Daring to dream the impossible dream for dementia care. Alzheimers Dement. 2017;13:1077–1080.
    1. Benbow S.M., Jolley D. Dementia: stigma and its effects. Neurodegener Dis Manag. 2012;2:165–172.
    1. Byrne P. Psychiatric stigma. Br J Psychiatry. 2001;178:281–284.
    1. Taylor A. The Effects of Stigma on Access to Care and Services. Presented at the Research Summit on Dementia Care, 2017.
    1. Corner L., Bond J. Being at risk of dementia: Fears and anxieties of older adults. J Aging Stud. 2004;18:143–155.
    1. Werner P., Giveon S.M. Discriminatory behavior of family physicians toward a person with Alzheimer's disease. Int Psychogeriatr. 2008;20:824–839.
    1. Wortmann M. Dementia: a global health priority–highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4:40.
    1. National Plan to Address Alzheimer's Disease: 2014 Update. ASPE, 23-Nov-2015. Available at:
    1. Alzheimer Europe. 2013 Alzheimer Europe Report: The Ethical Issues Linked to the Perceptions and Portrayal of Dementia and People with Dementia. 2013. Available at: . Accessed March 20, 2018.
    1. Advisory Council July 2017 Meeting Presentation: Implications of a Biologically Based Definition. ASPE, 27-Jul-2017. Available at:
    1. Gauthier S., Leuzy A., Racine E., Rosa-Neto P. Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues. Prog Neurobiol. 2013;110:102–113.
    1. Lecouturier J., Bamford C., Hughes J.C., Francis J.J., Foy R., Johnston M. Appropriate disclosure of a diagnosis of dementia: identifying the key behaviours of ‘best practice’. BMC Health Serv Res. 2008;8:95.
    1. Luck T., Luppa M., Sieber J., Schomerus G., Werner P., König H. Attitudes of the German General Population toward Early Diagnosis of Dementia – Results of a Representative Telephone Survey. PLoS One. 2012;7:e50792.
    1. Grill J.D., Apostolova L.G., Bullain S., Burns J.M., Cox C.G., Dick M. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017;9:35.
    1. Roberts J.S., Dunn L.B., Rabinovici G.D. Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues. Neurodegener Dis Manag. 2013;3:219–229.
    1. Stites S.D., Karlawish J., Harkins K., Rubright J.D., Wolk D. Awareness of mild cognitive impairment and mild Alzheimer's disease dementia diagnoses associated with lower self-ratings of quality of life in older adults. J Gerontol B Psychol Sci Soc Sci. 2017;72:974–985.
    1. Committee on Preventing Dementia and Cognitive Impairment, Board on Health Sciences Policy, Health and Medicine Division, and E . National Academies Press; Washington, D.C: 2017. National Academies of Sciences and Medicine, Preventing Cognitive Decline and Dementia: A Way Forward.
    1. Zhong Y., Karlawish J., Johnson M.K., Neumann P.J., Cohen J.T. The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of Clinicians. Alzheimer Dis Assoc Disord. 2017;31:27–33.
    1. Lingler J.H., Nightingale M.C., Erlen J.A., Kane A.L., Reynolds C.F. 3rd, Schulz R. Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience. Gerontologist. 2006;46:791–800.
    1. Mozersky J., Sankar P., Harkins K., Hachey S., Karlawish J. Comprehension of an elevated amyloid positron emission tomography biomarker result by cognitively normal older adults. JAMA Neurol. 2018;75:44–50.
    1. Milne R., Diaz A., Bunnik E., Badger S., Fauria K., Wells K. At, with and beyond risk: expectations of living with the possibility of future dementia. Sociol Health Illn. 2017 (in press)
    1. Lim Y.Y., Maruff P., Getter C., Snyder P.J. Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability. Alzheimers Dement J Alzheimers Assoc. 2016;12:454–458.
    1. Burns J.M., Johnson D.K., Liebmann E.P., Bothwell R.J., Morris J.K., Vidoni E.D. Safety of disclosing amyloid status in cognitively normal older adults. Alzheimers Dement J Alzheimers Assoc. 2017;13:1024–1030.
    1. Holroyd S., Turnbull Q., Wolf A.M. What are patients and their families told about the diagnosis of dementia? Results of a family survey. Int J Geriatr Psychiatry. 2002;17:218–221.
    1. Ritchie C.W., Russ T.C., Banerjee S., Barber B., Boaden A., Fox N.C. The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease. Alzheimers Res Ther. 2017;9:85.
    1. Kunneman M., Pel-Littel R., Bouwman F.H., Gillissen F., Schoonenboom N.S.M., Claus J.J. Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project. Alzheimers Dement (N Y) 2017;10:314–322.
    1. van der Flier W.M., Kunneman M., Bouwman F.H., Petersen R.C., Smets E.M.A. Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making. Alzheimers Dement Transl Res Clin Interv. 2017;3:301–304.
    1. Wadley V.G., Haley W.E. Diagnostic attributions versus labeling: impact of Alzheimer's disease and major depression diagnoses on emotions, beliefs, and helping intentions of family members. J Gerontol B Psychol Sci Soc Sci. 2001;56:P244–P252.
    1. Witte K., Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav. 2000;27:591–615.
    1. Werner P. Stigma and Alzheimer's disease: A systematic review of evidence, theory, and methods. In: Corrigan P.W., editor. The Stigma of Disease and Disability: Understanding Causes and Overcoming Injustices. American Psychological Association; Washington: 2014. pp. 223–244.
    1. Fernando S.M., Deane F.P., McLeod H.J. “Sri Lankan doctors' and medical undergraduates' attitudes towards mental illness. Soc Psychiatry Psychiatr Epidemiol. 2010;45:733–739.
    1. Low L.F., Anstey K.J., Lackersteen S.M., Camit M., Harrison F., Draper B. Recognition, attitudes and causal beliefs regarding dementia in Italian, Greek and Chinese Australians. Dement Geriatr Cogn Disord. 2010;30:499–508.
    1. Kubiak S.P., Ahmedani B.K., Rios-Bedoya C.F., Anthony J.C. Stigmatizing clients with mental health conditions: an assessment of social work student attitudes. Soc Work Ment Health. 2011;9:253–271.
    1. Corrigan P.W., River L.P., Lundin R.K., Penn D.L., Uphoff-Wasowski K., Campion J. Three strategies for changing attributions about severe mental illness. Schizophr Bull. 2001;27:187–195.
    1. Corrigan P.W., River L.P., Lundin R.K., Uphoff Wasowski K., Campion J., Mathisen J. Stigmatizing attributions about mental illness. J Community Psychol. 2000;28:91–102.
    1. Molina Y., Choi S.W., Cella D., Rao D. The Stigma Scale for Chronic Illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions. Int J Behav Med. 2013;20:450–460.
    1. Fife B.L., Wright E.R. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41:50–67.
    1. Pan A.-W., Chung L., Fife B.L., Hsiung P.-C. Evaluation of the psychometrics of the Social Impact Scale: a measure of stigmatization. Int J Rehabil Res. 2007;30:235–238.
    1. Stuart H., Milev R., Koller M. The Inventory of Stigmatizing Experiences: its development and reliability. World Psychiatry. 2005;4:33–37.
    1. Rao D., Choi S.W., Victorson D., Bode R., Peterman A., Heinemann A. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI) Qual Life Res. 2009;18:585–595.
    1. Gray H.L., Jimenez D.E., Cucciare M.A., Tong H.-Q., Gallagher-Thompson D. Ethnic differences in beliefs regarding Alzheimer disease among dementia family caregivers. Am J Geriatr Psychiatry. 2009;17:925–933.
    1. Otlowski M., Taylor S., Bombard Y. Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet. 2012;13:433–454.
    1. Genetic Information Nondiscrimination Act of 2008. National Human Genome Research Institute (NHGRI) Available at:
    1. Stanford University; Stanford, CA: 2014. Predicting Alzheimer's: The Social and Policy Implications of Early Diagnosis. Stanford Journal of Public Health.
    1. Zick C.D., Mathews C., Roberts J.S., Cook-Deegan R., Pokorski R.J., Green R.C. Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior. Health Aff (Millwood) 2005;24:483–490.
    1. Arias J.J., Karlawish J. Confidentiality in preclinical Alzheimer disease studies When research and medical records meet. Neurology. 2014;82:725–729.
    1. Alzheimer Europe 2016: Ethical issues linked to the changing definitions/use of the term Alzheimer's disease. 2016. Available at:
    1. Lu Y., Wang X. Correlation between insight and internalized stigma in patients with schizophrenia. Shanghai Arch Psychiatry. 2012;24:91–98.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit